Connect Biopharma Holdings Limited (CNTB) News
Track canonical SquawkNews coverage tagged to CNTB, Connect Biopharma Holdings Limited. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Connect Biopharma initiated with an Outperform at Oppenheimer
Oppenheimer initiated coverage of Connect Biopharma with an Outperform rating and $8 price target. Connect Biopharma is a single-asset story built on rademikibart, a next-generation human IgG4 anti-interleukin-4 receptor
EQUITY | Jul 09, 2026, 11:57 AM UTC
M
CNTB: Piper Sandler Initiates
Piper Sandler initiates coverage on Connect Biopharma Hldgs with an Overweight rating and a price target of $7.
EQUITY | Jun 26, 2026, 01:44 PM UTC
M
BDC: BUY @ Citi
Citi initiates BDC with a BUY rating, among other top initiations
EQUITY | Jun 26, 2026, 11:17 AM UTC